|
|
|
|
LEADER |
00000nam a2200000 a 4500 |
001 |
475001 |
003 |
ICU |
005 |
19950901000000.0 |
008 |
820326s1982 nyua b 10100 eng u |
010 |
|
|
|a 81040613
|
020 |
|
|
|a 0890047685
|
035 |
|
|
|a (ICU)BID6417833
|
035 |
|
|
|a (OCoLC)8212139
|
039 |
0 |
|
|a 2
|b 3
|c 3
|d 3
|e 3
|
040 |
|
|
|a DLC
|c DLC
|d ICU
|
041 |
0 |
|
|a eng
|
050 |
0 |
|
|a RC268.3
|b .H93 1982
|
082 |
0 |
|
|a 616.99/4/079
|2 19
|
245 |
0 |
0 |
|a Hybridomas in cancer diagnosis and treatment /
|c editors, Malcolm S. Mitchell, Herbert F. Oettgen.
|
260 |
0 |
|
|a New York :
|b Raven Press,
|c c1982.
|
300 |
|
|
|a xviii, 264 p. :
|b ill. ;
|c 26 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Progress in cancer research and therapy
|v v. 21
|
500 |
|
|
|a Proceedings of a workshop held Feb. 1981 at Bethesda, Md., sponsored by the Biological Response Modifier Program, Division of Cancer Treatment, National Cancer Institute.
|
504 |
|
|
|a Includes bibliographical references and index.
|
650 |
|
0 |
|a Cancer
|x Immunological aspects
|x Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2008100050
|
650 |
|
0 |
|a Monoclonal antibodies
|x Diagnostic use
|x Congresses.
|
650 |
|
0 |
|a Monoclonal antibodies
|x Therapeutic use
|x Congresses.
|
650 |
|
0 |
|a Hybridomas
|x Congresses.
|
650 |
|
7 |
|a Cancer
|x Immunological aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst00845383
|
650 |
|
7 |
|a Hybridomas.
|2 fast
|0 http://id.worldcat.org/fast/fst00964540
|
650 |
|
7 |
|a Monoclonal antibodies
|x Diagnostic use.
|2 fast
|0 http://id.worldcat.org/fast/fst01025549
|
650 |
|
7 |
|a Monoclonal antibodies
|x Therapeutic use.
|2 fast
|0 http://id.worldcat.org/fast/fst01025554
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
700 |
1 |
0 |
|a Mitchell, Malcolm S.
|0 http://id.loc.gov/authorities/names/n82057958
|1 http://viaf.org/viaf/100545
|
700 |
1 |
0 |
|a Oettgen, Herbert F.
|0 http://id.loc.gov/authorities/names/n81057083
|1 http://viaf.org/viaf/76958401
|
710 |
2 |
0 |
|a Biological Response Modifier Program (U.S.)
|0 http://id.loc.gov/authorities/names/n82069797
|1 http://viaf.org/viaf/152465518
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 428c9353-36af-58fc-a11a-b2e319d4cdd9
|s 5cfaacb5-ac1e-530b-b25b-adb127e84ee7
|
928 |
|
|
|t Library of Congress classification
|a RC268.3.H930 1982
|l ASR
|c ASR-SciASR
|i 1746566
|
927 |
|
|
|t Library of Congress classification
|a RC268.3.H930 1982
|l ASR
|c ASR-SciASR
|e CRERAR
|b 20910832
|i 1365714
|